Cellenis Exo-ME
Asset
Autologous extracellular vesicle skin booster technology to improve skin quality
- Stage
- Approved
- Modality
- Cell therapy
- Target
- Not known
- 2
- Indications
- 0
- Trials
- 1
- Developer
Indications
2Skin aging
Approved, prnewswire.com, 6 Oct 2026
Skin quality
Approved, prnewswire.com, 6 Oct 2026
In the full profile
- Owner and partners1
Every asset’s record: target, stage, trials and the evidence behind it.